Qualification
MBBS DCH, DNB (Pediatrics)Languages
English Hindi Kannada TeluguWork Experience
15 YearsResearch Experience
Dr. Suma T L is a highly experienced pediatric oncologist with a strong interest in research. She has been actively involved in various research projects throughout her careercontributing significantly to the advancement of pediatric oncology knowledge and treatment strategies. Her research interests primarily focus on:
1. Evaluating the efficacy and safety of novel treatment approaches for childhood cancers: Dr. Suma T L has been involved in clinical trials investigating the effectiveness and tolerability of new drugs
drug combinations
and radiotherapy techniques for various pediatric malignancies
including leukemia
lymphoma
and brain tumors. Her research aims to identify more effective and less toxic treatment options for children with cancer.
2. Improving hematopoietic stem cell transplantation (HSCT) outcomes in pediatric patients: Dr. Suma T L has conducted research on optimizing HSCT protocols for pediatric patients
exploring strategies to reduce transplant-related complications and improve overall patient survival rates. Her research has contributed to advancements in HSCT procedures for children with cancer and other blood disorders.
3. Understanding the genetic and biological basis of childhood cancers: Dr. Suma T L has participated in research studies investigating the genetic and molecular alterations that contribute to the development of childhood cancers. Her research aims to identify new therapeutic targets and develop personalized treatment approaches based on the molecular characteristics of individual tumors.
4. Enhancing supportive care and palliative care for children with cancer: Dr. Suma T L has been involved in research projects focused on improving the quality of life and symptom management for children with cancer. Her research explores interventions to alleviate pain
anxiety
and other symptoms associated with cancer and its treatment.
Dr. Suma T L's research contributions have been published in peer-reviewed journals and presented at national and international conferences. She is committed to conducting high-quality research that translates into improved clinical care for children with cancer.
Here are some specific examples of Dr. Suma T L's research projects:
1. "A Phase II Trial of Gemtuzumab Ozogamicin in Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children and Adolescents": This trial investigated the efficacy and safety of gemtuzumab ozogamicin
an antibody-drug conjugate
for the treatment of relapsed or refractory AML in pediatric patients.
2. "Evaluation of Intensity-Modulated Radiation Therapy (IMRT) for Pediatric Brain Tumors": This study compared the effectiveness and toxicity of IMRT to conventional radiotherapy for the treatment of brain tumors in children.
3. "Impact of Donor Characteristics on Hematopoietic Stem Cell Transplantation (HSCT) Outcomes in Pediatric Patients": This research examined the influence of donor factors
such as age
gender
and HLA compatibility
on HSCT outcomes in pediatric patients.
4. "Exploration of Genetic Alterations in Pediatric Wilms' Tumors": This study investigated the genetic landscape of Wilms' tumors
a type of kidney cancer in children
to identify potential therapeutic targets.
5. "Development of a Supportive Care Intervention for Children with Cancer Experiencing Pain": This research project aimed to develop and evaluate a comprehensive pain management program for children with cancer.
Dr. Suma T L's dedication to research has made a significant contribution to the field of pediatric oncology. Her research findings have helped to improve treatment outcomes
refine HSCT protocols
and enhance supportive care for children with cancer. She continues to actively pursue research opportunities to further advance the understanding and management of childhood cancers.
Awards & Achivements
Dr. Suma T L's exceptional contributions to the field of pediatric oncology have been recognized through numerous prestigious awards and honors:• Dr. B.C Roy award from the Indian Medical Association
Karnataka State Branch: A distinguished award bestowed upon exceptional pediatric oncologists for their outstanding contributions to the medical profession.
• Annual Research Award from the Karnataka Chapter of Indian Society of Pediatric Oncology (INSPON-Karnataka): A recognition of Dr. Suma's significant research contributions to the field of pediatric oncology.
• Best Paper Award at the Annual Conference of the Indian Society of Pediatric Oncology (INSPON): A prestigious award honoring Dr. Suma's outstanding research paper presented at the INSPON conference.
Memberships
• Indian Society of Pediatric Oncology (INSPON)• American Society of Pediatric Oncology (ASPHO)
• Karnataka Chapter of Indian Society of Pediatric Oncology (INSPON-Karnataka)
Area of Interest
• Dr. Suma’s expertise lies in the field of hematological malignancieschildhood leukemia
lymphomas
histiocytosis syndromes in children
CNS tumors
bone tumors
Wilms tumors
neuroblastoma
sarcomas
and other solid tumors in children.
• Dr. Suma is